| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/23/2012 | US20120046180 Releasable nonvolatile mass-label molecules |
| 02/23/2012 | US20120046177 Mostly Natural DNA Sequencing by Synthesis |
| 02/23/2012 | US20120045791 Method and a blood oxygen tester for detecting the arterial or venous blood |
| 02/23/2012 | US20120045790 Microdissection method and information processing system |
| 02/23/2012 | US20120045789 Method for Screening of Antiviral Agents |
| 02/23/2012 | US20120045788 Device for sample preparation |
| 02/23/2012 | US20120045787 Flexible micro-carrier system |
| 02/23/2012 | US20120045786 Opto-fluidic microscope diagnostic system |
| 02/23/2012 | US20120045785 Hybrid Prokaryotic-Eukaryotic Tubulins and Use Thereof |
| 02/23/2012 | US20120045784 Biotinidase assay |
| 02/23/2012 | US20120045777 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 02/23/2012 | US20120045775 Phosphospecific pak antibodies and diagnostic kits |
| 02/23/2012 | US20120045774 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy |
| 02/23/2012 | US20120045771 Method for analysis of nucleic acid populations |
| 02/23/2012 | US20120045770 Lung tissue model |
| 02/23/2012 | US20120045769 Cellular assay employing detectable protein |
| 02/23/2012 | US20120045768 Methods and compositions to detect and differentiate small rnas in rna maturation pathway |
| 02/23/2012 | US20120045767 Magnetic beads having surface glycoconjugates and use thereof |
| 02/23/2012 | US20120045766 Jarid1b for target gene of cancer therapy and diagnosis |
| 02/23/2012 | US20120045765 Composite liquid cells |
| 02/23/2012 | US20120045764 Method of expanding human hepatocytes in vivo |
| 02/23/2012 | US20120045763 Antibodies Against Cells of Fetal Origin |
| 02/23/2012 | US20120045762 Lmna gene and its involvement in hutchinson-gilford progeria syndrome (hgps) and arteriosclerosis |
| 02/23/2012 | US20120045761 Probes and primers for detection of chikungunya |
| 02/23/2012 | US20120045760 Single Nucleotide Polymorphism Within An Intronic P53 Binding Motif of the Prkag2 Gene |
| 02/23/2012 | US20120045759 Methods for detecting nucleic acid hybridization |
| 02/23/2012 | US20120045758 Imprinting in very small embryonic-like (vsel) stem cells |
| 02/23/2012 | US20120045757 Apparatus and methods for analysing fluorescent particles |
| 02/23/2012 | US20120045756 Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
| 02/23/2012 | US20120045755 Her-2 binding antagonists |
| 02/23/2012 | US20120045754 Novel gold nanostructures and methods of use |
| 02/23/2012 | US20120045753 Sequences diagnostic for shrimp pathogens |
| 02/23/2012 | US20120045752 Fiber sampler for recovery of bioaerosols and particles |
| 02/23/2012 | US20120045751 Generic Sample Preparation |
| 02/23/2012 | US20120045750 Kit for detecting hiv-2 and method for detecting hiv-2 using the same |
| 02/23/2012 | US20120045749 Methods of categorizing an organism |
| 02/23/2012 | US20120045748 Particulate labels |
| 02/23/2012 | US20120045747 Kit for detecting hepatitis b virus and method for detecting hepatitis b virus using the same |
| 02/23/2012 | US20120045514 Anti-cancer microparticle |
| 02/23/2012 | US20120045501 Connexin enhances chemotherapy-included apoptosis in human cancer cells inhibiting tumor cell proliferation |
| 02/23/2012 | US20120045476 Live attenuated mycoplasma strains |
| 02/23/2012 | US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof |
| 02/23/2012 | US20120045468 Immunogenic Compositions and Uses Thereof |
| 02/23/2012 | US20120045467 Influenza virus vaccine composition and methods of use |
| 02/23/2012 | US20120045465 Cancer antigen helper peptide |
| 02/23/2012 | US20120045459 Methods for Treating Autophagy-Related Disorders |
| 02/23/2012 | US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 02/23/2012 | US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 02/23/2012 | US20120045447 T cell costimulating polypeptides and uses thereof |
| 02/23/2012 | US20120045439 Tumor markers and methods of use thereof |
| 02/23/2012 | US20120045429 Methods and Agent for Modulating the RNA Polymerase II-Histone Surface |
| 02/23/2012 | US20120045425 Delta 4, 5 glycuronidase compositions and methods related thereto |
| 02/23/2012 | US20120045419 Methods and uses of hypoxic compartment cells |
| 02/23/2012 | US20120045399 Positively-charged superparamagnetic iron oxide nanoparticle, contrast agent using the same and method of preparing the same |
| 02/23/2012 | US20120045395 MicroRNAs In Idiopathic Pulmonary Fibrosis |
| 02/23/2012 | US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor |
| 02/23/2012 | US20120043204 Enzymatic reagent inks for use in test strips having a predetermined calibration code |
| 02/23/2012 | CA2808859A1 Cancer diagnostic and cancer therapeutic |
| 02/23/2012 | CA2808760A1 Method for isolating urea while removing undesirable co2 |
| 02/23/2012 | CA2808625A1 Small molecule arrays and methods for making and using them |
| 02/23/2012 | CA2808485A1 Methods and means for characterizing antibiotic resistance in microorganisms |
| 02/23/2012 | CA2808417A1 Circulating biomarkers for disease |
| 02/23/2012 | CA2807421A1 Fiber sampler for recovery of bioaerosols and particles |
| 02/23/2012 | CA2807209A1 Markers of the male urogenital tract |
| 02/23/2012 | CA2807104A1 Bard1 isoforms in lung and colorectal cancer and use thereof |
| 02/23/2012 | CA2716302A1 Compositions and methods for determining likelihood of an increased susceptibility to contract johne's disease |
| 02/22/2012 | EP2420579A1 Helicase dependent isothermal amplification using nicking enzymes |
| 02/22/2012 | EP2420578A1 A method for screening cancer |
| 02/22/2012 | EP2420577A1 Process to detect urea |
| 02/22/2012 | EP2420576A2 Use of HE4 and other biochemical markers for assessment of ovarian cancers |
| 02/22/2012 | EP2420575A2 Marker for prognosis of liver cancer |
| 02/22/2012 | EP2420574A1 Primer for detecting avellino corneal dystrophy |
| 02/22/2012 | EP2420573A1 Stable artificial bioluminescent enzyme having super-high brightness |
| 02/22/2012 | EP2420569A1 Method for culturing bone marrow stromal cells and mesenchymal stem cells, and method for producing graft cells for treating central neurological disease |
| 02/22/2012 | EP2420566A1 Method of preparing human lung tissue stem cells and method of inducing differentiation into human alveolar epithelial cells |
| 02/22/2012 | EP2420515A1 Diagnosis and treatment of cancer using anti-tmprss11e antibody |
| 02/22/2012 | EP2419737A2 Histone modification patterns for clinical diagnosis and prognosis of cancer |
| 02/22/2012 | EP2419724A2 Expanding the dynamic range of a test strip |
| 02/22/2012 | EP2419541A2 Quality control bioassays for nutriceutical and medicinal products |
| 02/22/2012 | EP2419540A1 Methods and gene expression signature for assessing ras pathway activity |
| 02/22/2012 | EP2419539A1 Predictive models and method for assessing age |
| 02/22/2012 | EP2419538A2 Methods and compositions to detect and differentiate small rnas in rna maturation pathway |
| 02/22/2012 | EP2419537A2 Methods and compositions for detection of small rnas |
| 02/22/2012 | EP2419536A1 Microrna as a biomarker of pancreatic islet beta-cell engagement |
| 02/22/2012 | EP2419535A1 Delivery of oligonucleotide-functionalized nanoparticles |
| 02/22/2012 | EP2419534A1 Signature of secreted protein isoforms specific to ovarian cancer |
| 02/22/2012 | EP2419533A1 Process for tumour characteristic and marker set identification, tumour classification and marker sets for cancer |
| 02/22/2012 | EP2419532A1 Methods and tools for predicting the efficiency of anthracyclines in cancer |
| 02/22/2012 | EP2419531A1 Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies |
| 02/22/2012 | EP2419530A1 System and method for detection of hla variants |
| 02/22/2012 | EP2419529A1 Inflammatory bowel disease prognostics |
| 02/22/2012 | EP2419528A1 Genetic loci associated with fusarium ear mold resistance in maize |
| 02/22/2012 | EP2419527A1 Method for the detection and characterization of a toxinogenic clostridium difficile strain |
| 02/22/2012 | EP2419526A1 Methods for selecting oocytes and competent embryos with high potential for pregnancy outcome |
| 02/22/2012 | EP2419525A1 Method of determining the activity of pkc-theta |
| 02/22/2012 | EP2419524A1 Detection of bacteria and fungi |
| 02/22/2012 | EP2419523A1 Diagnostic devices and related methods |
| 02/22/2012 | EP2419522A2 Methods and kits to predict therapeutic outcome of tyrosine kinase inhibitors |
| 02/22/2012 | EP2419512A1 Method of screening for insulin secretion-potentiating agents |
| 02/22/2012 | EP2419509A1 Development of fluorescently p-loop labelled kinases for screening of inhibitors |